Ingrid KromannHead of CMC at R&D CEPI
Ingrid Kromann started 01 March 2020 as Head of CMC, CEPI, UK. The CEPI CMC team is facilitating the vaccine developers in process development and scale up activities.
Ingrid has a background as chemical engineer. She has more than 25 years’ experience of working with vaccines through her employment at Statens Serum Institut, Denmark.
For the last 16 years, Ingrid led the Vaccine development department at Statens Serum Institut, and has developed more than 10 different vaccines from research to clinical trials, mostly within Tuberculosis, Polio and Chlamydia.